Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.

Autor: Sidey-Gibbons CJ; Section of Patient-Centered Analytics, Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, USA. cgibbons@Mdanderson.org., Sun C; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Schneider A; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Lu SC; Section of Patient-Centered Analytics, Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, USA., Lu K; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA., Wright A; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA.; Department of Medicine, Harvard Medical School, Boston, USA., Meyer L; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2022 Dec 08; Vol. 12 (1), pp. 21269. Date of Electronic Publication: 2022 Dec 08.
DOI: 10.1038/s41598-022-22614-1
Abstrakt: Contrary to national guidelines, women with ovarian cancer often receive treatment at the end of life, potentially due to the difficulty in accurately estimating prognosis. We trained machine learning algorithms to guide prognosis by predicting 180-day mortality for women with ovarian cancer using patient-reported outcomes (PRO) data. We collected data from a single academic cancer institution in the United States. Women completed biopsychosocial PRO measures every 90 days. We randomly partitioned our dataset into training and testing samples. We used synthetic minority oversampling to reduce class imbalance in the training dataset. We fitted training data to six machine learning algorithms and combined their classifications on the testing dataset into an unweighted voting ensemble. We assessed each algorithm's accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUROC) using testing data. We recruited 245 patients who completed 1319 PRO assessments. The final voting ensemble produced state-of-the-art results on the task of predicting 180-day mortality for ovarian cancer paitents (Accuracy = 0.79, Sensitivity = 0.71, Specificity = 0.80, AUROC = 0.76). The algorithm correctly identified 25 of the 35 women in the testing dataset who died within 180 days of assessment. Machine learning algorithms trained using PRO data offer encouraging performance in predicting whether a woman with ovarian cancer will die within 180 days. This model could be used to drive data-driven end-of-life care and address current shortcomings in care delivery. Our model demonstrates the potential of biopsychosocial PROM information to make substantial contributions to oncology prediction modeling. This model could inform clinical decision-making Future research is needed to validate these findings in a larger, more diverse sample.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje